What is the current valuation of the liquid biopsy market in India as of 2024?

The liquid biopsy market in India was valued at $363.96 Million in 2024. Read More

What is the projected market size for liquid biopsy in India by 2035?

The market is projected to reach $1,093.72 Million by 2035. Read More

What is the expected CAGR for the liquid biopsy market in India during the forecast period 2025 - 2035?

The expected CAGR for the liquid biopsy market in India during 2025 - 2035 is 10.52%. Read More

Which application segment holds the largest market share in the liquid biopsy market in India?

The Cancer Diagnosis segment held a valuation of $145.58 Million in 2024 and is expected to grow significantly. Read More

What are the key sample types used in the liquid biopsy market in India?

The primary sample types include Blood, Urine, Saliva, Pleural Fluid, and Cerebrospinal Fluid, with Blood valued at $145.58 Million in 2024. Read More

Which technology segment is anticipated to drive growth in the liquid biopsy market in India?

Next Generation Sequencing, valued at $100.0 Million in 2024, is anticipated to drive growth in the technology segment. Read More

What are the main end-use sectors for liquid biopsy in India?

The main end-use sectors include Hospitals, Diagnostic Laboratories, Research Institutes, and Pharmaceutical Companies, with Diagnostic Laboratories valued at $120.0 Million in 2024. Read More

Who are the key players in the liquid biopsy market in India?

Key players include Guardant Health, Exact Sciences, Freenome, GRAIL, Biocept, Foundation Medicine, Roche, Thermo Fisher Scientific, and Qiagen. Read More

How does the liquid biopsy market in India compare to other regions?

While specific regional comparisons are not provided, the growth trajectory in India appears promising with a projected market size of $1,093.72 Million by 2035. Read More

What factors are contributing to the growth of the liquid biopsy market in India?

Factors contributing to growth include advancements in technology, increasing cancer prevalence, and rising demand for non-invasive diagnostic methods. Read More

India Liquid Biopsy Market

ID: MRFR/HC/42983-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

India Liquid Biopsy Market Research Report By Types (Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, Others), By Application (Cancer Therapeutic Application, Reproductive Health, Others) and By Sample (Blood Sample, Urine Sample, Other) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Application (USD Million)
  1. 4.1.1 Cancer Diagnosis
  2. 4.1.2 Treatment Monitoring
  3. 4.1.3 Recurrence Monitoring
  4. 4.1.4 Clinical Trials
  5. 4.1.5 Research Applications
2. 4.2 Food, Beverages & Nutrition, BY Sample Type (USD Million)
  1. 4.2.1 Blood
  2. 4.2.2 Urine
  3. 4.2.3 Saliva
  4. 4.2.4 Pleural Fluid
  5. 4.2.5 Cerebrospinal Fluid
3. 4.3 Food, Beverages & Nutrition, BY Technology (USD Million)
  1. 4.3.1 Next Generation Sequencing
  2. 4.3.2 Digital PCR
  3. 4.3.3 Microfluidics
  4. 4.3.4 Exosome Isolation
  5. 4.3.5 Circulating Tumor Cells
4. 4.4 Food, Beverages & Nutrition, BY End Use (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Diagnostic Laboratories
  3. 4.4.3 Research Institutes
  4. 4.4.4 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Guardant Health (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Exact Sciences (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Freenome (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GRAIL (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Biocept (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Foundation Medicine (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Roche (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Thermo Fisher Scientific (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Qiagen (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY APPLICATION
3. 6.3 INDIA MARKET ANALYSIS BY SAMPLE TYPE
4. 6.4 INDIA MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 INDIA MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY SAMPLE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

Cancer Diagnosis
Treatment Monitoring
Recurrence Monitoring
Clinical Trials
Research Applications

Food, Beverages & Nutrition By Sample Type (USD Million, 2025-2035)

Blood
Urine
Saliva
Pleural Fluid
Cerebrospinal Fluid

Food, Beverages & Nutrition By Technology (USD Million, 2025-2035)

Next Generation Sequencing
Digital PCR
Microfluidics
Exosome Isolation
Circulating Tumor Cells

Food, Beverages & Nutrition By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓